[ad_1]
05 082 019
Signature of a protocol agreement to provide drugs to cancer patients who can not afford treatment
· AstraZeneca is a leading pharmaceutical company in the United Arab Emirates.
· The meeting witnessed the presentation of technological innovations aimed at providing integrated solutions to the patient.
Dubai, the Ministry of Health and Community Protection discussed with the AstraZeneca delegation the promotion of innovation in the pharmaceutical sector and continued cooperation in the development of treatments for chronic diseases such as pediatric diseases. asthma, diabetes and heart disease. AstraZeneca praised the ministry's efforts to accelerate the registration of medical services to patients and society, its innovative products to the UAE are among the first countries in the world after being approved by the US Food and Drug Administration (FDA) or by the European Medicines Authority (EMA), thanks to the legislative environment and investment conditions available in the UAE. L & # 39; s innovative.
This took place at a meeting with HE Dr. Amin Hussein Al Amiri, Deputy Under Secretary of Public Health Policy and Licensing, recently at the Ministry Office, a delegation of AstraZeneca, led by the Executive Director of Global Markets, Mr. Leon Wang. The ministry emphasized the importance of providing innovative ideas that support the strategic partnership in the pharmaceutical sector with international pharmaceutical companies in order to provide the best possible treatment to patients and support the UAE's economy. AstraZeneca has introduced the technology developments developed at its Wuxi headquarters in China, aimed at providing integrated solutions to the patient.
Signature of a memorandum of understanding
The visit was also marked by the signing of a Memorandum of Understanding in cooperation with AstraZeneca to provide medicines to patients unable to afford treatment, to those suffering from urinary tract infection, cancer lung, lymphoma patients and acute asthma. The memorandum was signed by HE Dr. Amin Al Amiri and the company, Mr. Leon Wang, in the presence of Ms. Rokia Al Bastaki, Director of Drug Administration, Ms. Rita Al Shalouhi, Drug Policy Expert and from a delegation of the company.
Patients will be able to obtain medication from AstraZeneca to provide them with appropriate treatment to ensure their continued access to medication in accordance with the treatment plan developed by physicians to follow and stop treatment within the prescribed timeframes.
Strengthen the values of community responsibility
Dr. Rokaya Al Bastaki, director of the Department of Medicine, said the memo was part of the Ministry of Health and Community Protection's program for patients, eighth of the year. AstraZeneca initiative that contributes to the promotion of corporate social responsibility values, emphasizing that this cooperation was not the first between the Ministry and AstraZeneca. As part of a Memorandum of Understanding (MOU) that dealt with the management of a number of patients for a full year.
She emphasized the Ministry's commitment to increasing patient support initiatives under its supervision, in cooperation and coordination with various institutions that can help strengthen patient services, by providing appropriate high quality drugs and treatments. , in line with the ministry's strategy to provide members of society with comprehensive and innovative health care in accordance with the highest international standards. .
Leon Wang, President and CEO of Global Markets, AstraZeneca, said that early availability and access to medicines distinguish the UAE from many Middle Eastern countries and reflect its leadership in health care. We are proud to develop a strong partnership with the Ministry of Health and Community Protection through the transfer of experiences and innovations, as well as by building capacity and awareness in many of our therapeutic areas.
"This initiative, which includes new innovative treatments for the treatment of certain cancers and respiratory conditions, allows qualified patients with limited health insurance, which does not cover the cost of a comprehensive treatment to complete the treatment, to receive free certain medicines from AstraZeneca. "
"We are committed to continuously providing innovative medicines and comprehensive solutions benefiting patients in the United Arab Emirates as a strategic partner of the Ministry of Health and Community Protection and our joint work to achieve the Emirates vision. United Arab Emirates 2021.
– end
For any inquiries or for further information, do not hesitate to contact us at any time.
The gift of the witness
Public Relations and Media Survey
00971505784522
Osama Al – Ansari
Public Relations and Media Survey
00971509194522
Mahmoud Suleiman
Public Relations and Media Survey
00971505874522
© Press Release 2019
Source link
